Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Concerto Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Concerto Biosciences

Concerto Biosciences

Series A

Concerto Biosciences: Revolutionizing microbe interaction analysis with high-tech, ultra-high throughput platform.

HQ
Cambridge, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Concerto Biosciences, founded in Cambridge, MA, is dedicated to revolutionizing humanity's relationship with microbes. The company's core mission is to harness microbial ecology to develop transformative products. Utilizing an ultra-high throughput platform, Concerto Biosciences measures how microbes interact with each other, enabling the creation of innovative microbial products. Their market focus includes sectors that benefit from advanced microbial analysis and product development, such as healthcare, agriculture, and biotechnology.

Notable affiliated people and investors include experts in microbiology and biotechnology, though specific names are not provided. Key achievements for Concerto Biosciences include the development of their high-tech microbe analysis platform, which has set new standards in experimental rigor for microbial product discovery. The overall impact of Concerto Biosciences lies in its potential to create groundbreaking microbial solutions that can address critical challenges in various industries, ultimately enhancing human health and environmental sustainability.

Concerto Biosciences - Similar Companies

The BioCollective logo

The BioCollective

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Biomiic logo

Biomiic

BiomeSense logo

BiomeSense

biomesense.com

Solarea Bio logo

Solarea Bio

solareabio.com

Kanvas Biosciences logo

Kanvas Biosciences

kanvasbio.com

Petri Bio logo

Petri Bio

petribio.com

BrilliantBiome logo

BrilliantBiome

brilliantbiome.com

Biosortia Microbiomics logo

Biosortia Microbiomics

biosortia.com

Selva logo

Selva

MarvelBiome logo

MarvelBiome

marvelbiome.com

Vedanta Biosciences logo

Vedanta Biosciences

vedantabio.com

Vulcan Biologics logo

Vulcan Biologics

AsimicA logo

AsimicA

asimica.com

Resilient Biotics logo

Resilient Biotics

Concerto Biosciences - Quick Facts

Who are Concerto Biosciences' competitors?

Companies similar to Concerto Biosciences include The BioCollective, Wild Microbes, Biomiic and BiomeSense.

When was Concerto Biosciences founded?

Concerto Biosciences was founded in 2020.

Where is Concerto Biosciences' headquarters located?

Concerto Biosciences' headquarters is located in Cambridge, MA, US.

When was Concerto Biosciences' last funding round?

Concerto Biosciences' most recent funding round was for $24.5M (USD) in March 2022.

How much has Concerto Biosciences raised to-date?

As of Mar 22, 2022, Concerto Biosciences has raised a total of $26M (USD).

How many employees does Concerto Biosciences have?

Concerto Biosciences has 11 employees as of Feb 5, 2024.

Concerto Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Microbial Products
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified